Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 140 participants.

Also called NCT07511361

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07511361
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07511361. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-23 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Acronym
KARDINAL-ASH
Condition
Hypertension
Condition
Acute Severe Hypertension
Condition
Hypertensive Emergency
Condition
Hypertensive Urgency
Intervention (Drug)
Tonlamarsen
Intervention (Drug)
Placebo
Lead sponsor
Kardigan, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07511361
Content hash
32ee363b5077adf50e7376403ee97eaf42b2d856e01015b3a1b42ea28b7a3212